Old Web
English
Sign In
Acemap
>
Paper
>
Upfront Treatment of FLT3-Mutated AML: A Look Back at the RATIFY Trial and Beyond
Upfront Treatment of FLT3-Mutated AML: A Look Back at the RATIFY Trial and Beyond
2020
Gina Keiffer
Kimberly L. Aderhold
Neil Palmisiano
Keywords:
Midostaurin
Internal medicine
first line
Oncology
Gilteritinib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
23
References
0
Citations
NaN
KQI
[]